✦ LIBER ✦

PPN7 THE WILLINGNESS-TO-PAY APPROACH IN THE COST-BENEFIT ANALYSIS: THE TREATMENT OF PATIENTS AFFECTED FROM PAINFUL PATHOLOGY

✍ Scribed by GL Colombo; M Caruggi; A Muzio

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Methylnaltrexone in the Treatment of Opi

✍ Michael Iskedjian; Shrividya Iyer; S. Lawrence Librach; Mike Wang; Bechara Farah 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 1018 KB

Willingness-to-pay and patient-defined b

✍ Müller, C.; Augustin, M. 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB

PCV72 COST-EFFECTIVENESS ANALYSIS OF ADD

✍ P Kutscherauer; R Kodym; D Bartaskova 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

No Survival Benefit from Adding Cetuxima

✍ Zhou, Si-wei; Huang, Yuan-yuan; Wei, Ying; Jiang, Zhi-min; Zhang, Yuan-dong; Yan 📂 Article 📅 2012 🏛 Public Library of Science 🌐 English ⚖ 533 KB

PRS26 COST-EFFECTIVENESS AND BUDGET IMPA

✍ RA Fernandes; ML Takemoto; FN Cukier; FC Guerra; RB Passos 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 79 KB